Tumor response to neoadjuvant chemotherapy predicts long-term survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: A secondary analysis of a randomized phase 3 clinical trial-Reference-Cited by-同舟云学术

Tumor response to neoadjuvant chemotherapy predicts long-term survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: A secondary analysis of a randomized phase 3 clinical trial

Published:2016-12-21 Issue:9 Volume:123 Page:1643-1652
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Peng Hao¹,Chen Lei¹,Li Wen-Fei¹,Guo Rui¹,Mao Yan-Ping¹,Zhang Yuan¹,Guo Ying²,Sun Ying¹,Ma Jun¹

Affiliation:

1. Department of Radiation Oncology; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine; Guangzhou China

2. Department of Clinical Trials Center; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine; Guangzhou China

Funder

Sun Yat-sen University Clinical Research 5010 Program

Health and Medical Collaborative Innovation Project of Guangzhou City, China

Planned Science and Technology Project of Guangdong Province

National Science and Technology Pillar Program during the Twelfth Five-year Plan Period

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference41 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin.,2015

2. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099;Al-Sarraf;J Clin Oncol.,1998